Molecular & Genomic Pathology
  • Home
  • About
    • History
    • News & Events
    • Directors
    • Faculty
    • Research
    • Careers
    • Contact Us
  • Solid Tumors
    • All Tests
    • Forms
    • Specimen Requirements
  • Hematological Malignancies
    • All Tests
    • Forms
    • Specimen Requirements
  • Genetics
    • Tests
    • Forms
    • Specimen Requirements
  • For Clients
    • Forms
    • Specimen Requirements
    • License / Accreditation
    • Billing

All Tests

  • ALK, RET, ROS1 fusion, MET amplification by FISH
  • B-Cell Clonality - IgH and IgK Rearrangement Testing
  • BiliSeq Test Details
  • BRAF Mutation Analysis (exon 15)
  • CALR (Calreticulin) Mutation Analysis
  • CEBPA Gene Sequencing
  • Double primary testing for tumor de novo vs. metastasis
  • EGFR Amplification, FISH
  • FLT3 Mutation Analysis – ITD and D835/836 Codon Analysis in Acute Myeloid Leukemia
  • Fragile X Trinucleotide Repeat Sizing
  • GlioSeq® Test Details
  • Hereditary Hemochromatosis Mutation Analysis
  • Hereditary Pancreatitis Mutation Panel
  • Huntington's Disease Trinucleotide Repeat Sizing
  • IDH1/IDH2 mutation analysis, brain tumors
  • JAK2 V617F Mutation Analysis
  • Methylation Array, CNS tumors
  • MGMT promoter methylation, brain tumors
  • Microsatellite Instability, CRC
  • NPM1 Quantitative Testing
  • UPMC Oncomine Test Details
  • PancreaSeq® Test Details
  • PD-L1 expression by IHC
  • SPINK1 - N34S Mutation in Pancreatitis
  • t(9;22) BCR-ABL1 RNA
  • T-Cell Clonality – TCRB and TCRG Rearrangement Testing
  • TP53 NGS
  • ThyroSeq® Test Details
  • VHL Sequencing for von Hippel-Lindau Disease
  • VHL, renal cell carcinoma












© 2025 UPMC | University of Pittsburgh Medical Center.
Designed and maintained by Enterprise Provider Solutions.
Send questions and comments to the Web Administrators.